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Abstract
The autonomic nervous system maintains homeostasis, which is the state of balance in the body. That balance can be
determined simply and noninvasively by evaluating heart rate variability (HRV). However, independently of autonomic control of
the heart, HRV can be influenced by other factors, such as respiratory parameters. Little is known about the relationship
between HRV and spirometric indices. In this study, our objective was to determine whether HRV correlates with spirometric
indices in adults without cardiopulmonary disease, considering the main confounders (e.g., smoking and physical inactivity).
In a sample of 119 asymptomatic adults (age 20–80 years), we evaluated forced vital capacity (FVC) and forced expiratory
volume in 1 s (FEV1). We evaluated resting HRV indices within a 5-min window in the middle of a 10-min recording period,
thereafter analyzing time and frequency domains. To evaluate daily physical activity, we instructed participants to use a triaxial
accelerometer for 7 days. Physical inactivity was defined aso150 min/week of moderate to intense physical activity. We found
that FVC and FEV1, respectively, correlated significantly with the following aspects of the RR interval: standard deviation of the
RR intervals (r=0.31 and 0.35), low-frequency component (r=0.38 and 0.40), and Poincaré plot SD2 (r=0.34 and 0.36).
Multivariate regression analysis, adjusted for age, sex, smoking, physical inactivity, and cardiovascular risk, identified the SD2
and dyslipidemia as independent predictors of FVC and FEV1 (R
2=0.125 and 0.180, respectively, for both). We conclude that
pulmonary function is influenced by autonomic control of cardiovascular function, independently of the main confounders.
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Introduction
The autonomic nervous system maintains visceral
functions through the activity of its sympathetic and
parasympathetic branches. At times, the two branches
operate in an antagonistic manner, generating a dynamic
balance known as autonomic control. Analysis of heart
rate variability (HRV) is a noninvasive and simple method for
assessing autonomic control of the heart. The oscillation in
the interval between consecutive heartbeats is an indicator
of the integrity of the cardiovascular system and its ability to
adapt to environmental changes (1).
Decreased HRV is associated with increased risk of
morbidity and mortality after acute myocardial infarction (2).
In addition, autonomic imbalance has been linked to the
development of a wide range of diseases, including arterio-
sclerosis, congestive heart failure, diabetic neuropathy,
obesity, depression, and stress (3–5).
The respiratory cycle also affects autonomic control.
The heart rate increases during inspiration and decreases
during expiration, causing fluctuations in HRV (6). This
physiological phenomenon is known as respiratory sinus
arrhythmia (RSA). There are several ways to measure
RSA, the most common being through analysis of the
high-frequency (HF) component of HRV (7). The spectral
variable HF is also referred to as RSA or respiratory rate
because it has the same range as typical healthy adult
respiration (7). This indicates that there is functional syn-
chrony between the heart and lungs. However, the relation-
ship between HRV and pulmonary function is unclear.
Many factors influence pulmonary and cardiac func-
tion. Pulmonary function is influenced by lifestyle and
cardiovascular risk factors such as obesity, high blood
pressure, high cholesterol, metabolic syndrome, physical
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inactivity, and smoking (8–14). Dyslipidemia and elevated
heart rate are independent risk factors for pulmonary func-
tion impairment (15). In addition, pulmonary function is
inversely associated with levels of inflammation-sensitive
plasma proteins (16). The role of lipids in inflammatory
processes is well known and might explain the role of
dyslipidemia in the development of pulmonary diseases
(16). Physical activity also plays an important role in
regulating cardiac and pulmonary function. Furthermore,
regular physical activity increases HRV by increasing
parasympathetic activity at rest. Moderate to vigorous
physical activity can reduce the decline in pulmonary
function among smokers, preventing the development
of chronic obstructive pulmonary disease (COPD) as
well as reducing mortality (17). Nevertheless, longtime
smokers present lung tissue remodeling and a pro-
nounced decline in pulmonary function with aging.
Moreover, HRV is compromised in smokers (18). Those
effects are attributable to increased release and reduced
catabolism of catecholamines, together with decreased
vagal tone (18). Increased activation of the sympathetic
nervous system in smokers has an important clinical role,
as has been widely reported (18–20).
Although the correlation between HRV and pulmonary
function has been investigated in respiratory diseases
such as COPD and asthma (21,22), few studies have
evaluated that correlation in healthy adults (23). We
hypothesized that lower HRV indices are associated with
impaired pulmonary function, independently of factors
such as smoking, level of physical activity in daily life, and
cardiovascular risk. Therefore, the objective of the present
study was to determine whether HRV correlates with the
main spirometric indices in asymptomatic adults, as well
as whether those correlations remain significant after
being adjusted for the main confounders.
Material and Methods
The Epidemiological Study of Human Movement and
Hypokinetic Diseases is a longitudinal, population-based
cohort study investigating whether sedentary behavior
and physical inactivity are associated with the occurrence
of hypokinetic diseases, especially cardiorespiratory dis-
eases. From those participating in this ongoing study, we
recruited 119 participants (50 men and 69 women) who
were asymptomatic and free of cardiorespiratory disease.
We excluded individuals with Chagas disease, acute
myocardial infarction, coronary heart disease, COPD,
uncontrolled hypertension, diabetes, evidence of osteoar-
ticular problems, or a recent history of respiratory infection, as
well as those with a high risk of cardiac disease and those
using cardiovascular drugs (e.g., beta-adrenoceptor antago-
nists). The study was approved by the Ethics Committee for
Research in Humans, Universidade Federal de São Paulo
(Protocol #186.796), and all participants provided their written
informed consent.
Health evaluation
During clinical evaluation of participants, we collected
data related to level of education and medication use. In
addition, we collected detailed information on the following
cardiovascular risk factors: age, obesity, family history of
cardiovascular disease, hypertension, dyslipidemia, seden-
tary lifestyle, angina (stable or unstable), dizziness, and
syncope. Dyslipidemia was defined as total cholesterol or
triglyceride levels higher than 240 mg/dL. Body mass
index (BMI) was calculated after measuring weight and
height on a scale equipped with a stadiometer (2124;
Toledo, Brazil). Participants with BMI X30 kg/m2 were
considered obese (24). Cardiovascular risk was classified
as mild or moderate according to the number of risk factors
(o2 or X2, respectively). Participants who reported current
smoking and having smoked at least 100 cigarettes in their
lifetime were classified as smokers (25,26). Smoking history
was calculated in pack-years. Participants were asked about
their history of COPD and asthma, as well as about expo-
sure to dusty environments and chemicals within the last
year.
Pulmonary function
We performed pulmonary function tests with a
spirometer (Quark PFT; Cosmed, Italy) using the forced
vital capacity (FVC) maneuver. The maneuver could be
repeated up to seven times until three results were
reproducible. The turbines were calibrated before each
test. Forced expiratory volume in 1 s (FEV1), FVC, and the
FEV1/FVC ratio were determined. Spirometric indices are
expressed as absolute values and as percentages of the
predicted values (27).
HRV
For each participant, we measured RR intervals using
a heart rate monitor (Polar RS800; Polar Electro Oy,
Finland), while the participant was at rest in the supine
position. Although intervals were monitored for 10 min, our
analysis included only the data obtained within a 5-min
window in the middle of the monitoring period, the initial
and final 150-s periods being excluded. The data were
then transferred to a computer and stored using com-
patible software (Polar ProTrainer 5; Polar Electro Oy).
The data were visually inspected, and any inappropriate or
premature beats were corrected by interpolation. Those
RR intervals showing a420% difference in relation to the
adjacent intervals were filtered (1). The results were then
stored in text files and transferred using Kubios HRV
version 2.2 software (University of Eastern Finland: http://
kubios.uef.fi/KubiosHRV/Download/). The linear indices
obtained in the time domain were as follows: the mean RR
interval, the root mean square of successive differences
between adjacent normal RR intervals, the standard
deviation of the RR intervals, the number of adjacent normal
RR intervals differing by 450 ms, and the proportion of
adjacent normal RR intervals differing by 450 ms. In the
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frequency domain, we obtained the following linear indices:
the HF component, the low-frequency (LF) component, and
the LF/HF ratio. The geometric indices assessed were short-
term variability (SD1) and long-term variability (SD2) of the
Poincaré plot (4). We also analyzed the nonlinear indices
a1 and a2 (28).
HRV can be influenced by various conditions including
blood pressure, anxiety, left ventricular ejection fraction,
lung volume, breathing pattern, respiratory frequency, and
medication use. To minimize such interference, all analyses
were performed at the same time of day, with participants at
rest in the supine position. Participants were instructed to
avoid drinking coffee, tea, soft drinks, and alcoholic bever-
ages, as well as to avoid engaging in physical activities and
avoid smoking before the HRV test. All participants
remained at rest for 5 min before the test. They were
instructed to breathe normally and avoid speaking during
the test.
Physical activity in daily life
The level of physical activity in daily life was measured
with a triaxial accelerometer (GT3X+; Actigraph, USA).
Each instrument was programmed according to the char-
acteristics of the participant (sex, age, dominant side,
height, and body mass). Participants were instructed to
wear the accelerometer at the waist above the domi-
nant hip for 7 days. They were instructed to remove the
accelerometer during sleeping and water activities, including
bathing. Only days with at least 12 h of continuous moni-
toring were considered valid. Energy expenditure was
measured and physical activity was classified as mild,
moderate, vigorous, or very vigorous (29). Participants
who were unable to engage in moderate to vigorous
physical activity for at least 150 min/week were consid-
ered physically inactive. Therefore, physical inactivity was
analyzed as a categorical variable.
Statistical analysis
Sample size was calculated based on the number of
predictors in the multiple regression models, as follows: age,
sex, BMI, HRV, smoking, physical inactivity, and cardiovas-
cular risk factors (family history of cardiovascular disease,
hypertension, dyslipidemia, angina, and syncope). Consid-
ering a correction coefficient (r) of 0.80 and a coefficient of
determination (R2) of 0.64, with 11 predictors, the minimum
sample size required for this study would be 110 participants.
In multivariate linear regressions, spirometric indices were
analyzed as outcomes.
Statistical analysis was performed using the IBM
SPSS Statistics, Version 23.0 (IBM Corp., USA). Data
were analyzed using descriptive statistics. We used the
Kolmogorov-Smirnov to assess data normality. Continu-
ous variables are presented as mean±standard deviation
or as median (interquartile range), depending on the distri-
bution of the data (symmetrical or asymmetrical). Categorical
variables are presented as frequencies. The Pearson or
Spearman correlation coefficient was used to evaluate the
correlations, also depending on the distribution of the
data. Stepwise multiple linear regressions were used to
identify correlations between HRV indices as predictors
and spirometric indices as outcomes. The HRV indices
were divided into time, frequency, and nonlinear domains.
Those HRV indices that presented the strongest correla-
tions with FEV1 and FVC in each category were selected
as predictors for inclusion in the regression models. The
multiple regression models were adjusted for the main
confounders, such as smoking and cardiovascular risk
including physical inactivity assessed directly by triaxial
accelerometry. We also adjusted the models for the use of
medications other than cardiovascular drugs. The prob-
ability of a type I error was set at 5%.
Results
Participants were, on average, middle-aged adults,
ranging in age from 20 to 80 years (Table 1). The mean
BMI was 27±5 kg/m2 (within the range of overweight),
and 31 (26.1%) of the 119 participants were obese.
According to the spirometric indices, the participants were
free of respiratory disturbances. However, nine partici-
pants (7.6%) had arterial hypertension, seven (5.9%) had
diabetes, and 24 (20.2%) had dyslipidemia. In addition,
19 (16%) were smokers and 14 (11.9%) were physically
inactive.
We found that HRV correlated moderately, but signifi-
cantly, with the spirometric indices (Table 2). The indices
representing parasympathetic and overall autonomic
control (standard deviation of the RR intervals, root mean
square of successive differences between adjacent normal
RR intervals, number of adjacent normal RR intervals
differing by 450 ms, proportion of adjacent normal RR
intervals differing by450 ms, HF component, SD1, and SD2)
presented positive correlations with spirometric indices. Those
representing sympathetic modulation (the LF component and
Table 1. General characteristics and pulmonary function in the
study sample.
Characteristic n=119
Age (years) 41±14
Weight (kg) 75±19
Height (m) 1.66±0.07
BMI (kg/m2) 27±5
FVC (L) 3.98±1.07
FVC (% of predicted) 97±13
FEV1 (L) 3.23±0.87
FEV1 (% of predicted) 95±13
FEV1/FVC (%) 82±5
Data are reported as means±SD. BMI: body mass index;
FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s.
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LF/HF ratio) presented negative correlations with those
indices. The nonlinear index a2 correlated significantly with
FVC. After multiple regression analysis, adjusted for the main
confounders, only SD2 of the Poincaré plot and dyslipidemia
remained as determinants of the spirometric indices (Table 3).
Discussion
Here, we have demonstrated that pulmonary func-
tion correlated significantly with several HRV indices in
asymptomatic adults. Although moderate, those correlations
remained significant regardless of cardiovascular risk. Among
cardiovascular risk factors, dyslipidemia was found to be the
most important predictor of pulmonary function.
After adjusting for the main confounders, we found that
the SD2 of the Poincaré plot remained as a determinant of
FVC and FEV1. SD2 has been associated with overall
HRV (1–3). Therefore, higher SD2 values indicate the
predominance of the parasympathetic nervous system in
autonomic balance. Although there have been few studies
evaluating the Poincaré plot in healthy participants at rest,
the evidence suggests that an increase in SD1 indicates
increased parasympathetic activity, whereas an increase
in SD2 indicates decreased sympathetic activity (1–3).
Given that FEV1 has been shown to be an important risk
factor for mortality and respiratory diseases (30) and that
FVC is considered a measure of pulmonary capacity (30),
our finding that autonomic control presented significant
positive correlations with spirometric indices suggests that
there is synchronicity between the activities of the lung
and those of the heart. The predominance of the para-
sympathetic nervous system might be related to respira-
tory efficiency. That finding is in agreement with those of
Hayano et al. (31), who showed that the HF component is
a measure of parasympathetic nervous system activity. In
the cardiopulmonary system, the HF component is an
intrinsic resting function aimed at optimizing pulmonary
function. It has also been suggested that the HF com-
ponent creates functional synchrony between the heart
and lungs by matching the timing of alveolar ventilation to
Table 3. Results of multiple linear regression analysis for FEV1 (L)
and FVC (L) models.
Coefficients (b) Standard error P
FEV1
Intercept 2.874 0.156 0.000
SD2 (ms) 0.007 0.002 0.001
Dyslipidemia  0.508 0.192 0.009
FVC
Intercept 3.632 0.220 0.000
SD2 (ms) 0.007 0.003 0.012
Dyslipidemia  0.541 0.245 0.029
Adjusted FEV1 R
2=0.180; adjusted FVC R2=0.125. FEV1: forced
expiratory volume in 1 s; FVC: forced vital capacity; SD2: long-term
variability of Poincaré plot. Adjusted for the main confounders (i.e.,
age, sex, smoking, cardiovascular risk, physical inactivity).
Table 2. Simple correlations between indices of heart rate variability (HRV) and spirometric indices.
Index FVC (L) FVC (%) FEV1 (L) FEV1 (%) FEV1/FVC (%) FEV1/FVC (% of pred.)
r r r r r r
SDRR (ms) 0.31* 0.07 0.34* 0.09 0.15 0.00
HR (bpm)  0.18*  0.05 0.14  0.02 0.08 0.12
RMSSD (ms) 0.27* 0.10 0.30* 0.13 0.14  0.01
NN50 0.29* 0.13 0.34* 0.18* 0.22* 0.03
pNN50 (%) 0.29* 0.14 0.32* 0.18* 0.17 0.00
HF (ms2) 0.25* 0.13 0.29* 0.17 0.13  0.05
HF (n.u.)  0.03 0.13 0.00 0.18* 0.06  0.00
LF (ms2) 0.38* 0.07 0.40* 0.09 0.14  0.04
LF (n.u.) 0.03  0.13 0.00  0.18*  0.06 0.00
LF/HF 0.07  0.12 0.04  0.19*  0.07  0.01
SD1 (ms) 0.27* 0.11 0.30* 0.14 0.16  0.01
SD2 (ms) 0.34* 0.07 0.36* 0.09 0.16 0.01
a1 0.11  0.00 0.08  0.08  0.07 0.00
a2  0.18*  0.13 0.18*  0.11  0.01  0.09
r values are reported for the Spearman correlations between HRV and spirometry indices (*Po0.05). FVC:
forced vital capacity; FEV1: forced expiratory volume in 1 s; SDRR: standard deviation of the RR intervals;
HR: heart rate; RMSSD: root mean square of successive differences between adjacent normal RR intervals;
NN50: number of adjacent normal RR intervals differing by450 ms; pNN50: proportion of adjacent normal
RR intervals differing by 450 ms; HF: high-frequency component; LF: low-frequency component; SD1:
short-term variability of Poincaré plot; SD2: long-term variability of Poincaré plot; a1: short fractal exponent;
a2: long-term fractal exponent.
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capillary perfusion during the respiratory cycle, increasing
the rate of gas exchange (32). However, even though the
HF component is considered a valid index of parasympa-
thetic nervous system input, the respiratory rate and tidal
volume might be confounders of the association between
the HF component and cardiac vagal tone (7). At rest
(when the cardiac vagal tone is constant), decreased tidal
volume and increased respiratory rate can attenuate the
HF component (8). Our results show that, in addition to the
HF component, SD2 is also related to synchronization of
cardiac and pulmonary function, being representative of
the autonomic balance. Rapid breathing is known to
greatly attenuate the HF component (32), which could
explain why we found that the HF component did not
correlate with the spirometric indices when we used the
FVC maneuver. Despite the modest R2 values, our results
suggest that autonomic control has an independent effect
on pulmonary function in adults.
To date, there have been few studies investigating the
correlations evaluated in the present study. To our knowl-
edge, only one study has addressed such correlations in
healthy adults; Behera et al. (23) also found that pulmonary
function presented positive bivariate correlations with the
parasympathetic and overall HRV indices, the HF compo-
nent and FEV1, and negative correlations with the sympa-
thetic HRV indices, the LF component and peak expiratory
flow in healthy adults. After linear regression analysis, the
authors observed a significant correlation between the HF
component and FEV1/FVC ratio, indicating that HRV is a
determinant of pulmonary function. However, only the
frequency domain of HRV was used and the regression
analysis was not adjusted for the main confounders, such as
physical inactivity and other cardiovascular risk factors. In
contrast, after adjusting for cardiovascular risk factors, we
found that the frequency domain of HRV was not an
important determinant of pulmonary function.
In the present study, multiple regression analysis
revealed that dyslipidemia was also a determinant of
pulmonary function (FEV1 and FVC). The important role of
cholesterol as an inflammatory regulator might partially
explain the relationship between pulmonary function and
dyslipidemia. In addition, there is a correlation between
total cholesterol and mortality from respiratory disease
(15). Furthermore, dyslipidemia has been shown to corre-
late negatively with FEV1 (33). Our results underscore
previous data indicating an inverse relationship between
dyslipidemia and pulmonary function. That relationship might
also be explained by the role of low density lipoprotein as an
optimizer of inflammation, which, in conjunction with oxida-
tive stress, increases the severity of pulmonary diseases
(34). Age also plays an important role in the association
between dyslipidemia and pulmonary function because
aging individuals tend to show declines in FEV1 and FVC,
as well as increased dyslipidemia (35). However, in the
present study, we found that dyslipidemia was predictive of
pulmonary function, even after adjusting for age. Therefore,
it is reasonable to assert that dyslipidemia could have dele-
terious effects on lung tissue, affecting spirometric indices
independently of other factors.
The association between pulmonary function and HRV
was also independent of smoking, physical inactivity, and
other cardiovascular risk factors. The influence of those
factors on pulmonary function has previously been
described (16,18,19). Among such factors, special atten-
tion should be given to physical activity in daily life,
measured directly as in the present study. In a recent
prospective study, an increase in physical activity level
was found to prevent a decline in FVC among adolescents
and young adults (36). In a 5-year cohort study (37), FEV1
was shown to increase by 50 mL in participants who
remained active, whereas it declined by 40 mL in those
who remained inactive. In an epidemiological study (38), a
relatively large proportion of never smokers were found to
have COPD (38). Certainly, there are other modifiable
genetic or environmental risk factors that determine
individual susceptibility (39). Although a low level of
physical activity in daily life has been described as a
consequence of COPD, recent studies raise the possibility
that inactivity is actually a risk factor for the development
and progression of the disease. It is plausible to suggest
that a low level of physical activity in daily life has negative
repercussions for pulmonary function because it increases
oxidative stress and inflammation, which are commonly
observed in sedentary individuals (40). In the present
study, we observed an influence of HRV on FEV1 and
FVC, independent of the well-established association
between daily physical activity and pulmonary function.
Therefore, our results suggest a complex interaction
among cardiovascular risk factors, autonomic balance,
and pulmonary function. Future studies should investigate
these relationships in a longitudinal manner.
The present study has certain limitations. Because this
was a cross-sectional study, we cannot know whether
improvement of the HRV indices would prevent a decline
in pulmonary function over time. In addition, we assessed
cardiovascular risk factors through interviews, which could
have led us to underestimate the influence of factors
such as hypertension and diabetes on pulmonary func-
tion. However, the previously described interaction among
inflammation, autonomic control, smoking, and physical
inactivity supports our results. Furthermore, the correla-
tions we observed between pulmonary function and auto-
nomic control in adults free of cardiorespiratory disease
have clinical relevance and should be considered when
assessing the risk of respiratory diseases.
We conclude that pulmonary function is positively
associated with autonomic control in asymptomatic adults,
regardless of the confounding effects of cardiovascular risk
factors. Among these factors, dyslipidemia seems to play an
important role in determining pulmonary function. Our results
suggest that increased parasympathetic activity is related to
increased respiratory efficiency, whereas dyslipidemia is
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related to decreased pulmonary function. Therefore, strate-
gies for improving autonomic control and reducing the
impact of dyslipidemia in asymptomatic adults should be
investigated in cohort studies, which might help prevent a
decline in pulmonary function over time. Our results highlight
the importance of the integrity of autonomic control to
pulmonary function in asymptomatic adults.
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